MARINUS PHARMACEUTICALS, INC. Selling, General and Administrative Expense
MARINUS PHARMACEUTICALS, INC. reported Selling, General and Administrative Expense of $12.57 million for the 3-month period ending 2024-09-30, per its 10-Q filed 2024-11-12.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:SellingGeneralAndAdministrativeExpense · last filed 2024-11-12
- MARINUS PHARMACEUTICALS, INC. selling, general and administrative expense for the quarter ending 2024-09-30 was $12.57M, a 15.44% decline year-over-year.
- MARINUS PHARMACEUTICALS, INC. selling, general and administrative expense for the quarter ending 2024-06-30 was $16.71M, a 6.28% increase year-over-year.
- MARINUS PHARMACEUTICALS, INC. selling, general and administrative expense for the quarter ending 2024-03-31 was $18.63M, a 22.51% increase year-over-year.
- MARINUS PHARMACEUTICALS, INC. selling, general and administrative expense for the quarter ending 2023-12-31 was $15.36M, a 4.78% increase year-over-year.
- MARINUS PHARMACEUTICALS, INC. selling, general and administrative expense for fiscal 2023 was $61.15M, a 7.58% increase from fiscal 2022.
- MARINUS PHARMACEUTICALS, INC. selling, general and administrative expense for fiscal 2022 was $56.84M, a 52.49% increase from fiscal 2021.
- MARINUS PHARMACEUTICALS, INC. selling, general and administrative expense for fiscal 2021 was $37.28M.
| Period end | Selling, General and Administrative Expense 3 month | Selling, General and Administrative Expense 6 month | Selling, General and Administrative Expense 9 month | Selling, General and Administrative Expense 12 month |
|---|---|---|---|---|
| 2024-09-30 | $12.57M 10-Q · filed 2024-11-12 | $29.28M derived: sum of 2 quarters · filed 2024-11-12 | $47.91M 10-Q · filed 2024-11-12 | $63.27M derived: sum of 4 quarters · filed 2024-11-12 |
| 2024-06-30 | $16.71M 10-Q · filed 2024-08-13 | $35.34M 10-Q · filed 2024-08-13 | $50.69M derived: sum of 3 quarters · filed 2024-08-13 | $65.56M derived: sum of 4 quarters · filed 2024-11-12 |
| 2024-03-31 | $18.63M 10-Q · filed 2024-05-08 | $33.98M derived: sum of 2 quarters · filed 2024-05-08 | $48.85M derived: sum of 3 quarters · filed 2024-11-12 | $64.57M derived: sum of 4 quarters · filed 2024-11-12 |
| 2023-12-31 | $15.36M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-05 | $30.23M derived: sum of 2 quarters · filed 2024-11-12 | $45.95M derived: sum of 3 quarters · filed 2024-11-12 | $61.15M 10-K · filed 2024-03-05 |
| 2023-09-30 | $14.87M 10-Q · filed 2024-11-12 | $30.59M derived: sum of 2 quarters · filed 2024-11-12 | $45.79M 10-Q · filed 2024-11-12 | $60.45M derived: sum of 4 quarters · filed 2024-11-12 |
| 2023-06-30 | $15.72M 10-Q · filed 2024-08-13 | $30.93M 10-Q · filed 2024-08-13 | $45.58M derived: sum of 3 quarters · filed 2024-08-13 | $58.97M derived: sum of 4 quarters · filed 2024-08-13 |
| 2023-03-31 | $15.20M 10-Q · filed 2024-05-08 | $29.86M derived: sum of 2 quarters · filed 2024-05-08 | $43.25M derived: sum of 3 quarters · filed 2024-05-08 | $60.31M derived: sum of 4 quarters · filed 2024-05-08 |
| 2022-12-31 | $14.66M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-05 | $28.05M derived: sum of 2 quarters · filed 2024-03-05 | $45.11M derived: sum of 3 quarters · filed 2024-03-05 | $56.84M 10-K · filed 2024-03-05 |
| 2022-09-30 | $13.39M 10-Q · filed 2023-11-07 | $30.45M derived: sum of 2 quarters · filed 2023-11-07 | $42.19M 10-Q · filed 2023-11-07 | $52.81M derived: sum of 4 quarters · filed 2023-11-07 |
| 2022-06-30 | $17.06M 10-Q · filed 2023-08-10 | $28.80M 10-Q · filed 2023-08-10 | $39.42M derived: sum of 3 quarters · filed 2023-08-10 | $48.87M derived: sum of 4 quarters · filed 2023-08-10 |
| 2022-03-31 | $11.74M 10-Q · filed 2023-05-11 | $22.36M derived: sum of 2 quarters · filed 2023-05-11 | $31.81M derived: sum of 3 quarters · filed 2023-05-11 | |
| 2021-12-31 | $10.62M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-09 | $20.07M derived: sum of 2 quarters · filed 2023-03-09 | $37.28M 10-K · filed 2023-03-09 | |
| 2021-09-30 | $9.45M 10-Q · filed 2022-11-07 | $26.66M 10-Q · filed 2022-11-07 |